VAV Life Sciences
- Company typePrivate
- Founded2003
- HeadquartersMumbai, India
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
VAV Life Sciences firmographics
Firmographics- Name
- VAV Life Sciences
- Legal name
- M S VAV Life Sciences Pvt. Ltd.
- Website
- https://vav.in
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
VAV Life Sciences industry classification
Industry- Product category
- Pharmaceutical Lipid Excipients
- NAICS
- Fats and Oils Refining and Blending (311225), Soybean and Other Oilseed Processing (311224), Medicinal and Botanical Manufacturing (325411), Starch and Vegetable Fats and Oils Manufacturing (31122)
- SIC
- Fats & Oils (2070), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Phospholipids & Lecithin Systems (Deoiled Lecithin, Fractionated Lecithins) (AFAJALAL)
- akta.pro secondary industries
- Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Lipid-Based Emulsions & Encapsulated Oils (Spray-Dried Oils, Microencapsulation) (AFAJALAM), Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL), Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)
Keywords
Where VAV Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
VAV Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Ingredient Sales: B2B sales of phospholipids, synthetic lipids, and lipid-based delivery systems to pharmaceutical companies for use in drug formulations, injectable emulsions, and active pharmaceutical ingredients.
- Nutraceutical Ingredient Sales: Sale of phospholipids, lecithins, and liposomal delivery systems to nutrition and supplement manufacturers for functional food, beverage, and nutraceutical applications.
- Cosmetic & Personal Care Ingredient Sales: Supply of phospholipid-based ingredients and liposomal systems to cosmetic and personal care product manufacturers for advanced skincare and dermatological formulations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B ingredient sales with customized pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
VAV Life Sciences product offering
Product offeringCore offering
VAV Life Sciences manufactures and supplies phospholipids, lecithins, synthetic lipids, and pre-formulated liposomal delivery systems derived from soy, sunflower, and egg sources. The company serves pharmaceutical, nutrition, and cosmetic manufacturers globally with ingredients for injectable emulsions, parenteral nutrition, advanced drug delivery (including lipid nanoparticles for mRNA therapeutics), bioavailability-enhanced nutraceuticals, and skin-penetration cosmetic formulations. Operations are GMP-certified and the product range spans commodity lecithins through ultra-pure injectable-grade phosphatidylcholines and ready-to-use liposomal actives.
Product overview
VAV Life Sciences is a leading manufacturer of phospholipids, lecithins, and lipid-based delivery systems serving pharmaceutical, nutrition & health, and cosmetic & personal care industries. The product portfolio includes Natural Phospholipids & Lecithins (LECIVA brand from soybean, sunflower, and egg sources), Synthetic Lipids (including DSPC, DPPC, DMPC, and anionic lipids), Neutral Lipids & Oils (cholesterol and OLEOVA egg oil), Choline Alfoscerate (Alpha-GPC) for cognitive health, and ready-to-use Phospholipid Systems including liposomal delivery complexes (LECIVA-CurLip, LECIVA-AscoLip, LECIVA-D3Lip, and others). Their products enable efficient incorporation of actives into stable, scalable formulations for drug delivery, nutritional supplements, and cosmetic applications.
Differentiator
Problem solved
Functional benefit
Brands
- LECIVA: Product line for natural phospholipids, lecithins, synthetic lipids, and related lipid ingredients sourced from soybean, sunflower, and egg. Includes variants like LECIVA-S (soy), LECIVA-M (sunflower), LECIVA-D (synthetic/specific phospholipids), LECIVA-PRO, LECIVA-IMMIX, and liposomal ingredient products such as LECIVA-AscoLip (vitamin C), LECIVA-CurLip (curcumin), LECIVA-GluLip (glutathione), and LECIVA-D3Lip (vitamin D3).
- LIPOVA
- LECIVA-GPC
Products and services
- Natural Phospholipids & Lecithins (LECIVA brand)
Quantifiable outcome
- Liposomal vitamin C demonstrates >2.5X higher Cmax, 6X longer Tmax, and 41X higher AUC compared to conventional vitamin C
- +5 more outcomes
Companies that use VAV Life Sciences
Customer profileNamed customers21 records
Segments3 records
Ideal customer profiles3 records
VAV Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
VAV Life Sciences partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
VAV Life Sciences competitors and assessment
Company assessmentDirect peers
- Lipoid GmbH: German phospholipid specialist with a near-identical product portfolio spanning natural (soy/sunflower/egg) lecithins, synthetic phospholipids, and liposomal systems for pharmaceutical, nutraceutical, and cosmetic applications. The closest comparable peer in technology, customer segments, and B2B ingredient positioning.
- Kewpie Corporation: Japanese food and pharmaceutical company with significant egg-derived phospholipid and lecithin manufacturing. Direct competitor in egg phospholipids (LIPOVA-equivalent product line) and in injectable emulsion excipient supply.
- Sternchemie: German lecithin and phospholipid manufacturer specializing in soy and sunflower lecithins for food, nutrition, and pharmaceutical applications. Highly comparable in product range, B2B ingredient model, and customer overlap.
- Fuji Oil Group: Japanese specialist in oilseed-derived ingredients including soy and sunflower lecithins/phospholipids for food and nutrition applications. Competes directly in the natural phospholipid and emulsifier line of business.
- NOF Corporation: Japanese manufacturer of pharmaceutical-grade phospholipids and lipid excipients (including PEGylated lipids) used in liposomal injectables and mRNA delivery. Directly competes in the synthetic phospholipid and LNP space.
- Avanti Polar Lipids (Croda): Specializes in high-purity natural and synthetic phospholipids for pharmaceutical and research applications, now part of Croda. Direct competitor in injectable-grade and LNP-relevant lipid excipients serving the same pharmaceutical customer base.
Emerging players
- CordenPharma: CDMO with growing capabilities in lipid nanoparticle formulation for mRNA and gene therapy. An emerging buyer/supply-chain participant in the LNP space that competes for the same biotech customers VAV serves with synthetic lipid excipients.
Broad incumbents
- Evonik (Specialty Additives): German specialty chemicals company with lipid-based excipients and pharmaceutical delivery systems. Overlaps in synthetic phospholipids and lipid excipients for pharma but as part of a much broader specialty chemicals portfolio.
- ADM (Animal Nutrition & Specialty Ingredients): Major oilseed processor with lecithin and phospholipid offerings as part of a broad food/feed ingredient portfolio. Competes in commodity-grade lecithin but lacks VAV's depth in pharmaceutical-grade and liposomal systems.
- Cargill (Lecithin & Specialty Oils): Global agricultural commodity and ingredient giant with a significant lecithin/oilseed processing business. Overlaps in food-grade and feed-grade lecithins but does not specialize in VAV's pharmaceutical/injectable-grade or liposomal delivery niche.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
VAV Life Sciences social profiles
Digital presenceVAV Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
VAV Life Sciences leadership team
Management profileNumber of profiles
VAV Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VAV Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VAV Life Sciences
What does VAV Life Sciences do?
VAV Life Sciences manufactures and supplies phospholipids, lecithins, synthetic lipids, and pre-formulated liposomal delivery systems derived from soy, sunflower, and egg sources. The company serves pharmaceutical, nutrition, and cosmetic manufacturers globally with ingredients for injectable emulsions, parenteral nutrition, advanced drug delivery (including lipid nanoparticles for mRNA therapeutics), bioavailability-enhanced nutraceuticals, and skin-penetration cosmetic formulations. Operations are GMP-certified and the product range spans commodity lecithins through ultra-pure injectable-grade phosphatidylcholines and ready-to-use liposomal actives.
Is VAV Life Sciences a public or private company?
VAV Life Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was VAV Life Sciences founded?
VAV Life Sciences was founded in 2003. It employs 51 to 100 people.
Where is VAV Life Sciences based?
VAV Life Sciences is headquartered in Mumbai, India, in the Asia region.
How does VAV Life Sciences make money?
Three revenue lines are on record. Pharmaceutical Ingredient Sales are the primary driver. The others are nutraceutical Ingredient Sales and cosmetic & Personal Care Ingredient Sales.
Who are VAV Life Sciences's main competitors?
Direct peers on record are Lipoid GmbH, Kewpie Corporation, Sternchemie, Fuji Oil Group, NOF Corporation and Avanti Polar Lipids (Croda). CordenPharma is listed as an emerging player. Broad incumbents are Evonik (Specialty Additives), ADM (Animal Nutrition & Specialty Ingredients) and Cargill (Lecithin & Specialty Oils).
Does VAV Life Sciences have an API?
No public API is recorded for VAV Life Sciences.
What industry is VAV Life Sciences in?
VAV Life Sciences's product category is Pharmaceutical Lipid Excipients. Its primary akta.pro industry code is AFAJALAL, Phospholipids & Lecithin Systems (Deoiled Lecithin, Fractionated Lecithins), with a secondary code of AFAJACAL, Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation). Its NAICS code is 311225 and its SIC code is 2070.